-
公开(公告)号:US06759223B2
公开(公告)日:2004-07-06
申请号:US10355975
申请日:2003-01-30
申请人: Timothy A. Bird , G. Duke Virca , Unja Martin , Dirk M. Anderson
发明人: Timothy A. Bird , G. Duke Virca , Unja Martin , Dirk M. Anderson
IPC分类号: C12N912
CPC分类号: C12N9/1205 , C12Q1/48 , C12Q1/485 , G01N2500/04
摘要: The invention is directed to purified and isolated novel murine and human kinase polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
摘要翻译: 本发明涉及纯化和分离的新型鼠和人激酶多肽,编码这种多肽的核酸,用于产生这些多肽的重组形式的方法,针对这些多肽产生的抗体,衍生自这些多肽的片段化肽,以及 以上。
-
公开(公告)号:US06514719B1
公开(公告)日:2003-02-04
申请号:US09579664
申请日:2000-05-26
申请人: Timothy A. Bird , G. Duke Virca , Unja Martin , Dirk M. Anderson
发明人: Timothy A. Bird , G. Duke Virca , Unja Martin , Dirk M. Anderson
IPC分类号: C12Q148
CPC分类号: C12N9/1205 , C12Q1/48 , C12Q1/485 , G01N2500/04
摘要: The invention is directed to purified and isolated novel murine and human kinase polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
摘要翻译: 本发明涉及纯化和分离的新型鼠和人激酶多肽,编码这种多肽的核酸,用于产生这些多肽的重组形式的方法,针对这些多肽产生的抗体,衍生自这些多肽的片段化肽,以及 以上。
-
公开(公告)号:US20080076141A1
公开(公告)日:2008-03-27
申请号:US11900984
申请日:2007-09-14
申请人: Timothy Bird , G. Virca , Unja Martin , Dirk Anderson
发明人: Timothy Bird , G. Virca , Unja Martin , Dirk Anderson
CPC分类号: C12N9/1205 , C12Q1/48 , C12Q1/485 , G01N2500/04
摘要: The invention is directed to purified and isolated novel murine and human kinase polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
摘要翻译: 本发明涉及纯化和分离的新型鼠和人激酶多肽,编码这种多肽的核酸,用于产生这些多肽的重组形式的方法,针对这些多肽产生的抗体,衍生自这些多肽的片段化肽,以及 以上。
-
公开(公告)号:US20060024807A1
公开(公告)日:2006-02-02
申请号:US11241056
申请日:2005-09-30
申请人: Timothy Bird , G. Virca , Unja Martin , Dirk Anderson
发明人: Timothy Bird , G. Virca , Unja Martin , Dirk Anderson
CPC分类号: C12N9/1205 , C12Q1/48 , C12Q1/485 , G01N2500/04
摘要: The invention is directed to purified and isolated novel murine and human kinase polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
摘要翻译: 本发明涉及纯化和分离的新型鼠和人激酶多肽,编码这种多肽的核酸,用于产生这些多肽的重组形式的方法,针对这些多肽产生的抗体,衍生自这些多肽的片段化肽,以及 以上。
-
公开(公告)号:US07285643B2
公开(公告)日:2007-10-23
申请号:US11241056
申请日:2005-09-30
申请人: Timothy A. Bird , G. Duke Virca , Unja Martin , Dirk M. Anderson
发明人: Timothy A. Bird , G. Duke Virca , Unja Martin , Dirk M. Anderson
IPC分类号: C07K16/00
CPC分类号: C12N9/1205 , C12Q1/48 , C12Q1/485 , G01N2500/04
摘要: The invention is directed to purified and isolated novel murine and human kinase polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
摘要翻译: 本发明涉及纯化和分离的新型鼠和人激酶多肽,编码这种多肽的核酸,用于产生这些多肽的重组形式的方法,针对这些多肽产生的抗体,衍生自这些多肽的片段化肽,以及 以上。
-
公开(公告)号:US07001752B1
公开(公告)日:2006-02-21
申请号:US09980464
申请日:2000-05-26
申请人: Timothy A. Bird , G. Duke Virca , Unja Martin , Dirk M. Anderson
发明人: Timothy A. Bird , G. Duke Virca , Unja Martin , Dirk M. Anderson
CPC分类号: C12N9/1205
摘要: The inventions is directed to purified and isolated novel murine and human kinase polypeptides, the nucleic acid encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
摘要翻译: 本发明涉及纯化和分离的新型鼠和人激酶多肽,编码此类多肽的核酸,用于产生这些多肽的重组形式的方法,针对这些多肽产生的抗体,衍生自这些多肽的片段化肽,以及 以上。
-
-
-
-
-